Elicitation of Rheumatologist Preferences for the Treatment of Patients with Rheumatoid Arthritis After the Failure of a First Conventional Synthetic Disease-Modifying Anti-Rheumatic Agent

INTRODUCTION: Rheumatoid arthritis (RA) clinical guidelines do not provide strong recommendations for the choice of disease-modifying anti-rheumatic drugs (DMARD) in patients with an inadequate response to methotrexate (MTX), and only limited evidence is available on factors influencing rheumatologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Senbel, Eric, Durand, Frederick, Roux, Baptiste, Badaoui, Fatima-Zohra, Fautrel, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217392/
https://www.ncbi.nlm.nih.gov/pubmed/33939171
http://dx.doi.org/10.1007/s40744-021-00311-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217392/
https://www.ncbi.nlm.nih.gov/pubmed/33939171
http://dx.doi.org/10.1007/s40744-021-00311-1

Ejemplares similares